BDTofa 5mg Tablets 10S

BDTOFA 5 mg Tablet contains Tofacitinib 5 mg, a targeted immunomodulatory medicine belonging to the Janus Kinase (JAK) inhibitor class. Tofacitinib works by inhibiting JAK enzymes involved in immune-system signalling, thereby helping reduce abnormal inflammatory activity in the body.

It is a prescription medicine used under medical supervision for certain inflammatory and autoimmune conditions. Depending on the patient's condition and doctor's assessment, tofacitinib may be prescribed for conditions including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis.

BDTOFA 5 mg is an oral tablet formulation containing Tofacitinib 5 mg. The medicine should be taken strictly in the dose and duration prescribed by the treating physician. The dose may vary depending on the condition being treated, kidney/liver function, age and other medicines being taken.

Tofacitinib affects the immune system and can increase the risk of serious infections. It also has important warnings concerning blood clots, cardiovascular events and certain malignancies. Patients should inform their doctor about any history of serious infection, tuberculosis, liver/kidney disease, blood disorders or cardiovascular problems before starting treatment.

It should not be self-medicated or started/stopped without a doctor's advice. This is especially important because it is an immunomodulatory prescription medicine.